Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 03 2020 - 8:15AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16
of the Securities Exchange Act of 1934
Date of Report: December 3, 2020
Commission File Number: 001-39307
Legend Biotech Corporation
(Exact Name of Registrant as Specified in its Charter)
2101
Cottontail Lane
Somerset, New Jersey 08873
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Legend Biotech Announces Appointment of Dr. Patrick Casey to the Board of Directors
On December 3, 2020, Legend Biotech Corporation (the Company) issued a press release announcing a new appointment to the Companys Board
of Directors. The press release is attached to this Form 6-K as Exhibit 99.1.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
LEGEND BIOTECH CORPORATION
(Registrant)
|
|
|
|
|
December 3, 2020
|
|
|
|
By:
|
|
/s/ Ying Huang
|
|
|
|
|
|
|
Ying Huang, Ph.D.
|
|
|
|
|
|
|
Chief Executive Officer and Chief Financial Officer
|
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Jul 2023 to Jul 2024